KENNETT SQUARE, Pa., May 05, 2017 -- Genesis HealthCare (NYSE:GEN), one of the nation’s largest providers of post-acute care, today announced that it expects to release its first quarter ended March 31, 2017 results before the market opens on Tuesday, May 9, 2017. A conference call and webcast will follow on Tuesday, May 9, 2017 at 10:00 a.m. Eastern Time to discuss the results.
To participate in the call, interested parties may dial (855) 849-2198. Alternatively, interested parties may access the call in listen-only mode at http://www.genesishcc.com/investor-relations. A replay of the conference call will also be available after 1:00 p.m. Eastern Time at http://www.genesishcc.com/investor-relations.
About Genesis HealthCare
Genesis HealthCare (NYSE:GEN) is a holding company with subsidiaries that, on a combined basis, comprise one of the nation's largest post-acute care providers in more than 450 skilled nursing centers and assisted/senior living communities in 30 states nationwide. Genesis subsidiaries also supply rehabilitation and respiratory therapy to approximately 1,700 locations in 45 states, the District of Columbia and China. References made in this release to "Genesis," "the Company," "we," "us" and "our" refer to Genesis Healthcare, Inc. and each of its wholly-owned companies. Visit our website at www.genesishcc.com.
CONTACT: Investor Relations Lori Mayer, Genesis HealthCare 610-925-2000


Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model
Goldman Sachs CEO David Solomon’s 2025 Pay Soars to $47 Million After Strong Deal-Making Year
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Toyota Recalls 162,000 Tundra Vehicles in U.S. Over Multimedia Display Issue
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors
CN Energy Group Inc. Stock Slides After Nasdaq Delisting Notice Over Bid Price Rule
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 



